SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 223
- Q2 2025, −83 vs. previous quarter
- 13F value
- $3.65B
- Reported value at the end of Q2 2025
- Superinvestors holding
- 1
- At the end of Q2 2025
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2024
- $191.6M
- +3,417.3% year over year
- Net income, FY2024
- -$258.1M
- No comparable prior period
- Free cash flow, FY2024
- -$180.1M
- No comparable prior period
- Revenue, Q1 FY2025
- $49.1M
- +133.7% year over year
Revenue flow, FY2024
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2024: $258.1M (134.7% of revenue).
Superinvestors holding SWTX, Q2 2025
Go to the superinvestors tab1 superinvestor reports holding SpringWorks Therapeutics, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
0.4%
SpringWorks Therapeutics, Inc.'s share of the portfolio
- Shares
- 501,989
- Value
- $23.6M
Latest insider trades
See all insider tradesOpen-market purchases and sales by SpringWorks Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Edris BadreddinChief Operating Officer | SSale | −20.0K | $54.23 | −$1.08M | −10.5%169.7K after | 4 lots10b5-1 |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Islam SaqibChief Executive Officer | SSale | −49.0K | $54.24 | −$2.66M | −4.9%954.9K after | 5 lots10b5-1 |
| Feb 24, 2025 (view filing) | Feb 20 | 4 days | Islam SaqibChief Executive Officer | SSale | −29.3K | $60.30 | −$1.77M | −2.8%1.03M after | 2 lots10b5-1 |
| Feb 24, 2025 (view filing) | Feb 20 | 4 days | Ashar BhaveshChief Commercial Officer | SSale | −1.02K | $61.19 | −$62.2K | −1.6%62.1K after | 10b5-1 |
| Feb 24, 2025 (view filing) | Feb 20 | 4 days | Lynch DanielDirector | SSale | −47.6K | $60.22 | −$2.87M | −36.5%82.9K after | 2 lots10b5-1 |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Islam SaqibChief Executive Officer | SSale | −10.7K | $59.92 | −$639.5K | −1.0%1.06M after | 10b5-1 |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Lynch DanielDirector | SSale | −400 | $60.00 | −$24.0K | −0.3%130.5K after | 10b5-1 |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Pichl DanielChief People Officer | SSale | −29.8K | $54.36 | −$1.62M | −37.0%50.8K after | 3 lots10b5-1 |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Lynch DanielDirector | SSale | −175.0K | $54.46 | −$9.53M | −57.2%130.9K after | 3 lots10b5-1 |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Islam SaqibChief Executive Officer | SSale | −48.0K | $53.30 | −$2.56M | −4.6%1.00M after | 10b5-1 |
Top 10 13F holders, Q2 2025
See all 223 holdersThe largest institutional positions in SpringWorks Therapeutics, Inc. at the end of Q2 2025; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,260,644 | $341.2M | 0.01% | +1,014,573+16.2% | Added |
| Vanguard Group Inc | 7,131,004 | $335.1M | 0.01% | +48,423+0.7% | Added |
| Glazer Capital, LLC | 4,107,199 | $193.0M | 6.91% | +4,107,199 | New |
| FIL Ltd | 3,013,959 | $141.6M | 0.12% | +3,013,959 | New |
| State Street Corp | 2,994,000 | $140.7M | 0.01% | +77,659+2.7% | Added |
| TIG Advisors, LLC | 2,611,074 | $122.7M | 6.70% | +2,359,400+937.5% | Added |
| HBK Investments L P | 2,608,340 | $122.6M | 2.18% | +2,608,340 | New |
| Goldman Sachs Group Inc | 2,275,449 | $106.9M | 0.02% | +1,649,354+263.4% | Added |
| Beryl Capital Management LLC | 2,117,575 | $99.5M | 14.99% | +2,117,575 | New |
| Magnetar Financial LLC | 2,052,642 | $96.5M | 0.47% | +2,052,642 | New |
Holders of 5% or more of SWTX
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of SpringWorks Therapeutics, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 13G/A | 9.62%7.16M shares | – | Feb 10, 20224 filings | Jan 31, 2025 | SEC |
| Hudson Bay Capital Management LP | 13G | 5.22%3.94M shares | New | Aug 8, 20251 filing | Aug 8, 2025 | SEC |
Politician trades
All politician trades in SWTX3 members of Congress reported 7 trades in SpringWorks Therapeutics, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 11, 2025 |  Josh Gottheimer House · NJ | Sell | $1K-$15K |
| Jul 10, 2025 |  Gilbert Ray Cisneros, Jr. House · CA | Sell | $15K-$50K |
| Feb 11, 2025 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Aug 15, 2024 | Josh Gottheimer House · NJ | Buy | $1K-$15K |
| Jul 9, 2024 | Josh Gottheimer House · NJ | Sell | $1K-$15K |
House · NJ · Aug 11, 2025
Sell$1K-$15K
House · CA · Jul 10, 2025
Sell$15K-$50K
House · CA · Feb 11, 2025
Buy$1K-$15K
House · NJ · Aug 15, 2024
Buy$1K-$15K
House · NJ · Jul 9, 2024
Sell$1K-$15K